Industry
Biotechnology
Topic
Financial Results
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Financial Results in Biotechnology
... CANADIAN DAILY STOCK REPORT Immunoprecise Antibodies Ltd. (TSXV:IPA) has increased 1.0c (1.9%) from its last trading session of ...
... CANADIAN RESULTS ProMetic Life Sciences (TSX:PLI) reported loss for the quarter-ended 30 September 2017 of CAD15.5m ...
... 11.9% of its portfolio, respectively. Its top three holdings are biopharmaceutical company Biogen, healthcare insurer UnitedHealth Group and telco conglomerate Comcast. The fund returned a ...
... CANADIAN DAILY STOCK REPORT Ceapro Inc. (TSXV:CZO), Canada's 25th largest Biotechnology company by market cap, has climbed 3.0c ...
... (valsartan) oral solution in the United States and its territories from Carmel Biosciences, Inc. ("Carmel") for a seven year term with extensions to the term ...
... CANADIAN DAILY STOCK REPORT Immunoprecise Antibodies Ltd. (TSXV:IPA) has soared 6.0c (11.3%) from its last trading session of ...
... CANADIAN DAILY STOCK REPORT Neptune Technologies & Bioressources Inc. (TSX:NEPT), Canada's 11th largest Biotechnology company by market ...
... is on track to submit an IND by the end of 2017. Kleo Investment Kleo Pharmaceuticals, Inc. (Kleo) is a privately held, preclinical-stage company founded ...
... order to focus on his additional responsibilities as Interim Chief Medical Officer. Calyxt, Inc. - Cellectis' plant science subsidiary Calyxt's herbicide-tolerant wheat, its third wheat ...
... CAMBRIDGE, Mass. - Jounce Therapeutics, Inc.(NASDAQ: JNCE), a clinical stage company focused on the discovery and development ...
... p.m. ET - FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company pioneering the field of regenerative medicine, ...
... SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... Regulatory News: Cellectis S.A. (Paris:ALCLS)(NASDAQ:CLLS) (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused ...
... CANADIAN WEEKLY STOCK REPORT Aurinia Pharmaceuticals Inc. (TSX:AUP), Canada's 2nd largest Biotechnology company by market cap, has decreased ...
... BioCardia®, Inc .[OTC: BCDA], a leader in the development of comprehensive solutions for ...
... CANADIAN DAILY STOCK REPORT ProMetic Life Sciences Inc. (TSX:PLI), Canada's largest Biotechnology company by market cap, has fallen ...
... launches in history. Demand for SPINRAZA remains strong in the U.S., with Biogen reporting a 75% increase in the number of patients on therapy in ...
... have the potential to receive a future $ 22 million payment from Verastem upon the first regulatory approval of duvelisib, which we out-licensed in 2016, ...
... -BioCryst Reports Third Quarter 2017 Financial Results ...
... the 9th World Congress of Melanoma in October 2017 by the National Cancer Institute (NCI): Two (6%) objective responses were observed in 31 patients to ...
... CAMBRIDGE, Mass. - Acceleron Pharma Inc. (NASDAQ: XLRN), a leading biopharmaceutical company in the discovery and development of ...
... 14:17 EST ORIGINAL ANNOUNCEMENT [Text] LAVAL, QC, Nov. 9, 2017 - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic") today announced that it will ...
... Intrexon Corporation(NYSE: XON), a leader in the engineering and industrialization of biology to improve ...
... Pfenex Inc. (NYSE American: PFNX) is a clinical-stage biotechnology company developing complex therapeutic ...
... Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic")today announced that it will report ...
... PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver ...
... addition, it has been approximately 1.7 years without a lost-time injury at True North. -- Consolidated performance - The Company mined a total of 54,172 ...
... VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines ...
... GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel ...
... 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is focused ...
... BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company developing and ...
... Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of ...
... JUPITER, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic") (OTCQX:DYAI), a global biotechnology company focused on further improving and ...
... HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle ...
... Tumors Expressing HER2 CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a ...
... at 8:30am ET GAITHERSBURG, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three- ...
... WOBURN, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three and nine months ...
... China and CUPERTINO, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a clinical-stage biopharmaceutical company engaged in ...
... our unique business model and capabilities." Mr. Sharma continued, "Our acquisition of vivoPharm is an excellent example of our commitment as we seek to broaden ...
... YONKERS, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein ...
... 8:30 a.m. ETÂ WALTHAM, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that ...
... SOUTH SAN FRANCISCO, CA --(Marketwired - November 09, 2017) - VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines ...
Want to see the full history of news? Upgrade to RelSci Professional now!
Start My Free Trial